Founded in 2015, Exploring Health LLC has been dedicated to researching and developing new drugs for inhibiting tumor metastasis and promoting wound healing. Since the outbreak of the COVID-19 pandemic in 2020, all Exploring Health LLC members have devoted themselves to developing new antiviral drugs for COVID-19 treatment, and to make historic breakthroughs in the fight against the pandemic.

Using our self-developed high-throughput screening system, we succeeded in finding a compound that can effectively block the infection of human cells by the psuedo-SARS-CoV-2 virus, and obtained a Patent Certificate of the People’s Republic of China entitled “Anti-coronavirus drug based on ACE2 and S protein binding targets and application thereof” (Certificate Number: 4863105, Patent Number: ZL -2021-1-0165852.6).

We firmly believe that the development and utilization of this new drug will help combat the ongoing COVID-19 pandemic. In order to speed up our success in overcoming the pandemic, all of our shareholders, in the spirit of fraternity, benevolence, and compassion, have decided to contribute to the patent’s rights for public use. Any person or company can inform us and use this patent for free in fighting COVID-19. The contact email address is:

lgeorge@exploringhealth.cn

Although Exploring Health is still in its infancy and we have spent a large amount of money and resources in developing new drugs, all our shareholders are determined to contribute the patent’s rights to all of mankind without hesitation. As always, we will cultivate our competence in new drug research and development and fight shoulder to shoulder with the rest of the world to curb the COVID-19 outbreak. We hope we will emerge from this dark moment into a brighter future as soon as possible.